Oct 15, 2023, 14:10
Jennifer Buell: SaponiQx, an Agenus Inc. company revolutionizes access with sustainable, scalable supply of the vital QS-21 STIMULON
Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared on X/Twitter:
“SaponiQx, an Agenus Inc. company revolutionizes access with sustainable, scalable supply of the vital QS-21 STIMULON; a key component in vaccines, including GSK Shingrix (protection > 9 years) and world’s first malaria vax Mosquirix“
For details click here.
Source: Jennifer Buell/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 10:08
Nov 16, 2024, 10:06
Nov 16, 2024, 10:02
Nov 16, 2024, 10:00
Nov 16, 2024, 09:57
Nov 16, 2024, 09:51
Nov 16, 2024, 09:44
Nov 16, 2024, 09:31
Nov 16, 2024, 09:30